Schnurman Z, Mashiach E, Link KE et al (2023) Causes of death in patients with brain metastases. Neurosurgery 93(5):986–993

Article  PubMed  Google Scholar 

Sacks P, Rahman M (2020) Epidemiology of brain metastases. Neurosurg Clin N Am 31(4):481–488

Article  PubMed  Google Scholar 

Sperduto PW, Mesko S, Li J et al (2020) Survival in patients with brain metastases: summary report on the updated Diagnosis-Specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38(32):3773–3784

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6(1):1–9

Article  CAS  PubMed  Google Scholar 

Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22(1):97–104 viii

Al-Shamy G, Sawaya R (2009) Management of brain metastases: the indispensable role of surgery. J Neurooncol 92(3):275–282

Article  PubMed  Google Scholar 

Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494–500

Article  CAS  PubMed  Google Scholar 

Wroński M, Lederman G (1997) A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 80(5):1002–1004

Article  PubMed  Google Scholar 

Mintz AH, Kestle J, Rathbone MP et al (1996) A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78(7):1470–1476

Article  CAS  PubMed  Google Scholar 

Noordijk EM, Vecht CJ, Haaxma-Reiche H et al (1994) The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29(4):711–717

Article  CAS  PubMed  Google Scholar 

Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040–1048

Article  PubMed  PubMed Central  Google Scholar 

Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29(2):134–141

Article  PubMed  Google Scholar 

Churilla TM, Handorf E, Collette S et al (2017) Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952–26001. Ann Oncol 28(10):2588–2594

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atalar B, Modlin LA, Choi CY et al (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713–718

Article  PubMed  Google Scholar 

Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049–1060

Article  PubMed  PubMed Central  Google Scholar 

Akanda ZZ, Hong W, Nahavandi S, Haghighi N, Phillips C, Kok DL (2020) Post-operative stereotactic radiosurgery following excision of brain metastases: A systematic review and meta-analysis. Radiother Oncol 142:27–35

Article  PubMed  Google Scholar 

Lau S, Poletes C, Le LW et al (2021) Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapy. Lung Cancer 156:76–81

Article  CAS  PubMed  Google Scholar 

Khan M, Zhao Z, Li X, Liao G (2021) Anti-PD1 therapy plus Whole-Brain radiation therapy May prolong PFS in selected Non-Small cell lung cancer patients with brain metastases: A retrospective study. Int J Gen Med 14:8903–8918

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Li H, Peng L et al (2021) Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases. Ann Palliat Med 10(9):9974–9983

Article  PubMed  Google Scholar 

Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M et al (2021) Primary analysis and 4-Year Follow-Up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases. Clin Cancer Res 27(17):4737–4745

Article  PubMed  Google Scholar 

Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M et al (2024) Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial. Eur J Cancer 199:113531

Article  PubMed  Google Scholar 

Deng G, Tan X, Li Y et al (2023) Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis. Front Oncol 13:1049855

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J, Choi Y, Han J et al (2020) Osimertinib improves overall survival in patients with EGFR-Mutated NSCLC with leptomeningeal metastases regardless of T790M mutational status. J Thorac Oncol 15(11):1758–1766

Article  CAS  PubMed  Google Scholar 

Shaw AT, Bauer TM, de Marinis F et al (2020) First-Line lorlatinib or Crizotinib in advanced ALK-Positive lung cancer. N Engl J Med 383(21):2018–2029

Article  CAS  PubMed  Google Scholar 

Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270–e278

Article  PubMed  Google Scholar 

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247

Article  CAS  PubMed  Google Scholar 

Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National cancer Institute of the united States, National cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216

Article  CAS  PubMed  Google Scholar 

Cao Y, Xu W, Liu Q (2024) Alterations of the blood-brain barrier during aging. J Cereb Blood Flow Metab 44(6):881–895

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alsousli M, Maire CL, Piffko A et al (2025) Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis. Acta Neuropathol Commun 13(1):95

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Jagodinsky JC, Callahan SC et al (2025) Genomic and immune landscape of Non-Small cell lung cancer brain metastases. JCO Precis Oncol 9:e2400690

Article  PubMed  Google Scholar 

Kayama T, Sato S, Sakurada K et al (2018) Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): A Phase III, Noninferiority, randomized controlled trial. J Clin Oncol. : JCO2018786186

Kępka L, Tyc-Szczepaniak D, Bujko K et al (2016) Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: results from a randomized trial. Radiother Oncol 121(2):217–224

Article  PubMed  Google Scholar 

Foreman PM, Jackson BE, Singh KP et al (2018) Postoperative radiosurgery for the treatment of metastatic brain tumor: evaluation of local failure and leptomeningeal disease. J Clin Neurosci 49:48–55

Article  PubMed